Is it time to end lone-wolf medicine?

Por Loblaw, Andrew
Publicado no Can Urol Assoc J (2016)

Vitamin E might increase risk of death

Por Lock, Michael, Loblaw, Andrew
Publicado em 2005

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience

Por Musunuru, Hima Bindu, Cheung, Patrick, Loblaw, Andrew
Publicado no Front Oncol (2014)

Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline

Por Haider, Masoom A., Yao, Xiaomei, Loblaw, Andrew, Finelli, Antonio
Publicado no Can Urol Assoc J (2017)

Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)

Por Gladwish, Adam, Pang, Geordi, Cheung, Patrick, D’Alimonte, Laura, Deabreu, Andrea, Loblaw, Andrew
Publicado no Radiat Oncol (2014)

Systematic review of clinical features of suspected prostate cancer in primary care

Por Young, Sheila-Mae, Bansal, Praveen, Vella, Emily T., Finelli, Antonio, Levitt, Cheryl, Loblaw, Andrew
Publicado no Can Fam Physician (2015)

Guideline for referral of patients with suspected prostate cancer by family physicians and other primary care providers

Por Young, Sheila-Mae, Bansal, Praveen, Vella, Emily T., Finelli, Antonio, Levitt, Cheryl, Loblaw, Andrew
Publicado no Can Fam Physician (2015)

Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR)

Por Nicolae, Alexandru, Davidson, Melanie, Easton, Harry, Helou, Joelle, Musunuru, Hima, Loblaw, Andrew, Ravi, Ananth
Publicado no Radiat Oncol (2015)

Improved wait time intervals for prostate cancer patients in a multidisciplinary rapid diagnostic unit compared to a community-based referral pattern

Por Sethukavalan, Perakaa, Zhang, Liying, Jethava, Vibhuti, Stevens, Christiaan, Flax, Stanley, Buckley, Roger, Bondy, Susan, Loblaw, Andrew
Publicado em 2013

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials

Por Quon, Harvey C., Musunuru, Hima Bindu, Cheung, Patrick, Pang, Geordi, Mamedov, Alexandre, D’Alimonte, Laura, Deabreu, Andrea, Zhang, Liying, Loblaw, Andrew
Publicado no Front Oncol (2016)

Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program

Por Guy, David, Ghanem, Gabriella, Loblaw, Andrew, Buckley, Roger, Persaud, Beverly, Cheung, Patrick, Chung, Hans, Danjoux, Cyril, Morton, Gerard, Noakes, Jeff, Spevack, Les, Hajek, David, Flax, Stanley
Publicado no Can Urol Assoc J (2016)

CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update

Por Saad, Fred, Hotte, Sebastien, Catton, Charles, Drachenberg, Darrel, Finelli, Antonio, Fleshner, Neil, Gleave, Martin, Kapoor, Anil, Kassouf, Wassim, Loblaw, Andrew, North, Scott, Usmani, Nawaid, Chi, Kim N.
Publicado em 2013

Prostate-Specific Antigen Test for Prostate Cancer Screening: American Society of Clinical Oncology Provisional Clinical Opinion

Por Nam, Robert K., Oliver, Thomas K., Vickers, Andrew J., Thompson, Ian, Kantoff, Philip W., Parnes, Howard L., Loblaw, Andrew, Roth, Bruce J., Williams, Jim, Temin, Sarah, Basch, Ethan
Publicado em 2012

The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC)

Por Saad, Fred, Chi, Kim N., Finelli, Antonio, Hotte, Sebastien J., Izawa, Jonathan, Kapoor, Anil, Kassouf, Wassim, Loblaw, Andrew, North, Scott, Rendon, Ricardo, So, Alan, Usmani, Nawaid, Vigneault, Eric, Fleshner, Neil E.
Publicado no Can Urol Assoc J (2015)

Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer

Por Ghiam, Alireza Fotouhi, Taeb, Samira, Huang, Xiaoyong, Huang, Vincent, Ray, Jessica, Scarcello, Seville, Hoey, Christianne, Jahangiri, Sahar, Fokas, Emmanouil, Loblaw, Andrew, Bristow, Robert G., Vesprini, Danny, Boutros, Paul, Liu, Stanley K.
Publicado no Oncotarget (2016)